Variant report
Variant | nsv968911 |
---|---|
Chromosome Location | chr5:50570110-50572356 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:23)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:23 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr5:50571772-50571936 | GM12878 | blood: | n/a | n/a |
2 | CEBPB | chr5:50572053-50572521 | ECC-1 | luminal epithelium: | n/a | chr5:50572287-50572298 |
3 | CEBPB | chr5:50572129-50572535 | ECC-1 | luminal epithelium: | n/a | chr5:50572287-50572298 |
4 | CEBPB | chr5:50572120-50572466 | A549 | lung: | n/a | chr5:50572287-50572298 |
5 | CEBPB | chr5:50572111-50572457 | HepG2 | liver: | n/a | chr5:50572287-50572298 |
6 | CEBPB | chr5:50572257-50572301 | H1-hESC | embryonic stem cell: | n/a | chr5:50572287-50572298 |
7 | CEBPB | chr5:50572100-50572466 | Hela-S3 | cervix: | n/a | chr5:50572287-50572298 |
8 | CTCF | chr5:50571840-50571990 | GM12865 | blood: | n/a | n/a |
9 | CTCF | chr5:50571760-50571910 | MCF-7 | breast: | n/a | n/a |
10 | CTCF | chr5:50571716-50572082 | MCF-7 | breast: | n/a | n/a |
11 | CTCF | chr5:50571810-50571975 | MCF-7 | breast: | n/a | n/a |
12 | CTCF | chr5:50571780-50571930 | GM12871 | blood: | n/a | n/a |
13 | CTCF | chr5:50571684-50572144 | MCF-7 | breast: | n/a | n/a |
14 | CTCF | chr5:50571800-50572016 | MCF-7 | breast: | n/a | n/a |
15 | CTCF | chr5:50571800-50571950 | GM12874 | blood: | n/a | n/a |
16 | CTCF | chr5:50571780-50571930 | MCF-7 | breast: | n/a | n/a |
17 | EP300 | chr5:50572169-50572734 | ECC-1 | luminal epithelium: | n/a | chr5:50572288-50572302 |
18 | MAZ | chr5:50570860-50570964 | HepG2 | liver: | n/a | n/a |
19 | NFIC | chr5:50572058-50572833 | ECC-1 | luminal epithelium: | n/a | n/a |
20 | POLR2A | chr5:50571104-50571204 | Gliobla | brain: | n/a | n/a |
21 | RAD21 | chr5:50571734-50572146 | MCF-7 | breast: | n/a | chr5:50571735-50571744 |
22 | TEAD4 | chr5:50572086-50572752 | ECC-1 | luminal epithelium: | n/a | n/a |
23 | TEAD4 | chr5:50572169-50572756 | ECC-1 | luminal epithelium: | n/a | n/a |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:50258485..50259288-chr5:50571370..50571987,2 | MCF-7 | breast: | |
2 | chr5:50260308..50260944-chr5:50571869..50572389,2 | MCF-7 | breast: | |
3 | chr5:50571410..50572428-chr5:50643087..50644166,3 | MCF-7 | breast: | |
4 | chr5:50572356..50575340-chr5:50576089..50578064,2 | MCF-7 | breast: | |
5 | chr5:50258512..50259359-chr5:50571455..50572343,4 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ISL1-2 | chr5:50571087-50571568 | NONHSAT101386 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000240627 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs373362059 | chr5:50570135-50570136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs185884112 | chr5:50570157-50570158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs558904468 | chr5:50570196-50570197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs190310068 | chr5:50570214-50570215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs542571106 | chr5:50570227-50570228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs147580383 | chr5:50570246-50570247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs182025695 | chr5:50570276-50570277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs185746508 | chr5:50570299-50570300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs564682421 | chr5:50570395-50570396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs533346836 | chr5:50570405-50570406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs543563119 | chr5:50570464-50570465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs149052822 | chr5:50570506-50570507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs190109703 | chr5:50570560-50570561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs77000469 | chr5:50570584-50570585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs566048149 | chr5:50570645-50570646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs143051455 | chr5:50570708-50570709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs551901133 | chr5:50570717-50570718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs377743466 | chr5:50570782-50570783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs537549818 | chr5:50570884-50570885 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs370863958 | chr5:50570885-50570886 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs79501030 | chr5:50570897-50570898 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs181050973 | chr5:50570900-50570901 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs536526700 | chr5:50570916-50570917 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs553029511 | chr5:50570939-50570940 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs112265465 | chr5:50570941-50570942 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs201954922 | chr5:50571025-50571026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs375021116 | chr5:50571050-50571051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs145509002 | chr5:50571083-50571084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs574954590 | chr5:50571084-50571085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs543919641 | chr5:50571087-50571088 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs138048034 | chr5:50571089-50571090 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs574185618 | chr5:50571127-50571128 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs543295740 | chr5:50571137-50571138 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs368331015 | chr5:50571155-50571156 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs10939904 | chr5:50571182-50571183 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs185428933 | chr5:50571197-50571198 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs191211275 | chr5:50571258-50571259 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs530997351 | chr5:50571271-50571272 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs541633578 | chr5:50571292-50571293 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs10471515 | chr5:50571293-50571294 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs550826044 | chr5:50571301-50571302 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs567440350 | chr5:50571331-50571332 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs575102280 | chr5:50571341-50571342 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs182484801 | chr5:50571345-50571346 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs566386077 | chr5:50571353-50571354 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs10471516 | chr5:50571372-50571373 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs558097462 | chr5:50571380-50571381 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs574917340 | chr5:50571383-50571384 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs537929477 | chr5:50571388-50571389 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs554406280 | chr5:50571401-50571402 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21364760 | CNVD |
Oral cancer | 21386901 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 21911935 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:50567200-50574400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
2 | chr5:50569200-50574200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr5:50569800-50574400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
4 | chr5:50570000-50574200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |